Alzamend Neuro
ALZN
ALZN
15 hedge funds and large institutions have $9.41M invested in Alzamend Neuro in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
25% less funds holding
Funds holding: 20 → 15 (-5)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Holders
15
Holding in Top 10
–
Calls
$652K
Puts
$57K
Top Buyers
| 1 | +$4.8M | |
| 2 | +$709K | |
| 3 | +$577K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$51K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$39.7K |
Top Sellers
| 1 | -$88K | |
| 2 | -$73K | |
| 3 | -$56K | |
| 4 |
Millennium Management
New York
|
-$43K |
| 5 |
KCIA
Kingsbury Capital Investment Advisors
Wilmette,
Illinois
|
-$22K |